Hiroshi Sugiura
Overview
Explore the profile of Hiroshi Sugiura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawa R, Sugiura H, Hato Y, Kawahara H, Shiraki N, Ito Y, et al.
Case Rep Oncol
. 2025 Feb;
18(1):92-99.
PMID: 39980511
Introduction: Low-grade adenosquamous carcinoma (LGASC) is categorized as a metaplastic carcinoma but differs from other types of metaplastic carcinoma in having a more favorable prognosis. Due to its rarity and...
2.
Tanaka K, Abe K, Koizumi M, Takahashi T, Sugiura H
Asian J Endosc Surg
. 2024 Jun;
17(3):e13325.
PMID: 38839103
Thanatophoric dysplasia (TD) is a rare and severe type of skeletal dysplasia. Typical clinical findings include macrocephaly, shortening of the four limbs, underdeveloped lungs, and thoracic hypoplasia. Neonates with TD...
3.
Hisada T, Kondo N, Wanifuchi-Endo Y, Osaga S, Fujita T, Asano T, et al.
Sci Rep
. 2022 Oct;
12(1):16515.
PMID: 36192404
Lethal giant larvae homolog 2 (LLGL2) and solute carrier family 7 member 5 (SLC7A5) have been reported to be involved in resistance to endocrine therapy. This study aimed to assess...
4.
Terada M, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Hisada T, et al.
Breast Cancer Res Treat
. 2022 Aug;
195(3):311-323.
PMID: 35941421
Purpose: Vaccination is an essential strategy to prevent infection in the SARS-CoV-2 pandemic. However, there are concerns about vaccine efficacy and the impact of vaccination on cancer treatment. Additionally, the...
5.
Nakashima Y, Mori Y, Sugiura H, Hirose E, Toyoshima K, Masutani S, et al.
J Cardiol
. 2022 Jun;
80(4):344-350.
PMID: 35725946
Background: The frequency, mortality, and morbidity of very low birth weight (VLBW) infants with congenital heart disease (CHD) in Asian countries are limited. In addition, little is known about the...
6.
Ito T, Noritake K, Ito Y, Tomita H, Mizusawa J, Sugiura H, et al.
Sci Rep
. 2022 May;
12(1):7822.
PMID: 35551257
We aimed to develop gait standards for gait parameters in school-aged Japanese children and assess age-related differences in gait patterns and parameters. Children aged 6-12 years (n = 424) were...
7.
Uemoto Y, Katsuta E, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, et al.
Am J Cancer Res
. 2022 May;
12(4):1593-1605.
PMID: 35530276
HECT domain E3 ubiquitin ligase 1 (HECTD1) has been reported to be a negative regulator of epithelial-mesenchymal transition and to decrease breast cancer invasion and metastasis. However, the clinical significance...
8.
Wanifuchi-Endo Y, Kondo N, Dong Y, Fujita T, Asano T, Hisada T, et al.
Oncol Lett
. 2022 Jan;
23(2):60.
PMID: 34992692
Taxanes are important drugs used in the treatment of breast cancer; however, some cancer types are taxane-resistant. The aim of the present study was to investigate the underlying mechanisms of...
9.
Uemoto Y, Uchida M, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, et al.
Breast Cancer
. 2021 Jul;
28(6):1346-1357.
PMID: 34292500
Background: Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined...
10.
Nishikawa S, Uemoto Y, Kim T, Hisada T, Kondo N, Wanifuchi-Endo Y, et al.
Breast Cancer Res Treat
. 2021 Mar;
187(1):81-93.
PMID: 33782811
Purpose: Retinoic acid-induced 2 (RAI2) has been shown to be a putative suppressor of the early hematogenous dissemination of tumor cells to the bone marrow in breast cancer. Here, we...